Meeting
Abstract Number: 404
SHM Converge 2021
Case Presentation: A 45 year-old Cambodian female with no past medical history presented to the clinic with a mild cough. Her medical history was notable for never smoking, occasional alcohol use, and no recreational drug use. She had no known occupational exposures and no family history of malignancy. Initial treatment for gastroesophageal reflux disease and [...]
Abstract Number: 501
SHM Converge 2021
Case Presentation: A 70-year-old male with a past medical history of hypertension and diabetes was sent to the emergency room by primary care physician because of persistent hypokalemia while taking oral potassium supplements. Patient reported generalized weakness, low back pain, thirty-pound weight loss and poor appetite for a few months. He smokes one packet of [...]
Abstract Number: 622
SHM Converge 2021
Case Presentation: A 94-year-old woman with a history of atrial fibrillation (not on anticoagulation), coronary artery disease, and metastatic lung adenocarcinoma (on Osimertinib) presented following a syncopal episode, which was complicated by a left thigh hematoma. On admission, she was hemodynamically stable, although her bloodwork was concerning for disseminated intravascular coagulation (DIC) including a hemoglobin [...]
Abstract Number: 638
SHM Converge 2021
Case Presentation: A 59 year-old female with past medical history significant for chronic hyponatremia and tobacco use presented to the hospital with complaints of dyspnea and neck pain for 2 weeks. She reported blurry vision and swelling in her neck, face and axillae. Initial vitals were stable. Admission labs were significant for sodium 125, baseline [...]
Abstract Number: 703
SHM Converge 2021
Case Presentation: A 66-year-old female with metastatic small cell lung cancer involving brain, liver, and bones was admitted via ED with generalized weakness, mild confusion, and decreased oral intake for 3 days. She was initiated on immunotherapy with immune checkpoint inhibitors, ipilimumab (human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody) and nivolumab (a programmed death receptor-1 [...]